US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

101.14

-2.7909-2.69%

Post-market: 101.140.00000.00%16:10 EDT

Volume:11.31K

Turnover:1.15M

Market Cap:121.37M

PE:- -

High:104.53

Open:104.18

Low:100.91

Close:103.93

52wk High:110.05

52wk Low:68.05

Shares:1.20M

Float Shares:1.20M

Volume Ratio:1.26

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Steady unemployment gives RBA room to raise interest rates

The West Australian

Yomiuri: Japan's Basic Policy Reviewed to Ease Market 'shock'

Memphasys Plans 8 Million-Share Placement on ASX

Trex Acquisition Appoints Post Oak As M&A Advisor

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

Evofem Biosciences Updates Investors via New Presentation

3 Small-Cap ETFs With More Than 20% Upside, According to Wall Street

Amneal receives FDA approval for additional iohexol strengths, presentations

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

IMF warns Bank of England against cutting interest rates

Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab

Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million

Regeneron’s dupilumab granted orphan drug designation

Celcuity announces FDA approval of Revtorpyk

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure

Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BBP/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":101.1392,"timestamp":1789502400000,"preClose":103.9301,"halted":0,"volume":11309,"hourTrading":{"tag":"盘后","latestPrice":101.1392,"preClose":101.1392,"latestTime":"16:10 EDT","volume":8,"amount":809.1136,"timestamp":1789503007758,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.026853625658014316,"floatShares":1200004,"shares":1200004,"eps":0,"marketStatus":"Post-Mkt","change":-2.7909,"latestTime":"09-15 17:20:09 EDT","open":104.18,"high":104.53,"low":100.905,"amount":1146399,"amplitude":0.034879,"askPrice":115.89,"askSize":100,"bidPrice":91.28,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.9301,"sharesOutstanding":600004,"nav":103.362,"aum":124035301.07,"bidAskSpread":0.00263,"preHourTrading":{"tag":"盘前","latestPrice":103.9301,"preClose":103.9301,"latestTime":"07:02 EDT","volume":1,"amount":103.9301,"timestamp":1789470128746,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":101.1392,"preClose":101.1392,"latestTime":"16:10 EDT","volume":8,"amount":809.1136,"timestamp":1789503007758,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.256639,"impliedVol":0.2191,"impliedVolPercentile":0.3825},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1200004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.256639,"shares":1200004,"dividePrice":0,"high":104.53,"amplitude":0.034879,"preClose":103.9301,"low":100.905,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":101.1392,"eps":0,"divideRate":0,"volume":11309,"delay":0,"ttmEps":0,"open":104.18,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":106.7132,"twentyDayClose":102.7277,"sixtyDayClose":90.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653779091","title":"Steady unemployment gives RBA room to raise interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2653779091","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653779091?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:43","pubTimestamp":1784742186,"startTime":"0","endTime":"0","summary":"The Reserve Bank of Australia still has room to raise interest rates with unemployment holding steady in June.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22616252/36e3c96957a99b802801837643a9dc296ec5784b-16x9-x0y0w1280h720.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22616252/36e3c96957a99b802801837643a9dc296ec5784b-16x9-x0y0w1280h720.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/economy/australia-unemployment-holds-at-44-per-cent-in-june-as-rba-interest-rate-decision-comes-into-focus-c-22616252","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/economy/australia-unemployment-holds-at-44-per-cent-in-june-as-rba-interest-rate-decision-comes-into-focus-c-22616252","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["ANEW","BK4588","DFUV","KOMP","TSDD","BBP","TSYY","TSLI","TSLL","UCC","TSLQ","IJK","CRSH","CGDV","FXL","TSLT","09366","TSL","07766","CLIX","TSLG","VAW","FXR","TSLR","TSLY","RJZ","TSLS","TEST","TLA","TSLZ","09766","TSLP","TSLW","PEVC","AVSD","TESL","07366","TSII","LRCY","TSLO","BK4585","CAOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653507227","title":"Yomiuri: Japan's Basic Policy Reviewed to Ease Market 'shock'","url":"https://stock-news.laohu8.com/highlight/detail?id=2653507227","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653507227?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:34","pubTimestamp":1784723640,"startTime":"0","endTime":"0","summary":"Japan's Basic Policy on Economic and Fiscal Management and Reform 2026 adopted Tuesday by the Cabinet was a response to the so-called basic policy shock, the selloff of bonds and yen triggered by the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLW","RJZ","TSLQ","BK4585","TSDD","TSLG","TSLY","ANEW","CLIX","FXL","TLA","09766","TSLL","UCC","TSLZ","BK4588","CGDV","TSLO","TSYY","TSLT","TESL","TEST","AVSD","09366","TSLI","LRCY","CRSH","TSII","07366","TSLP","VAW","07766","FXR","TSLR","TSL","KOMP","PEVC","CAOS","BBP","TSLS","IJK","DFUV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653787553","title":"Memphasys Plans 8 Million-Share Placement on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2653787553","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653787553?lang=en_us&edition=fundamental","pubTime":"2026-07-22 09:27","pubTimestamp":1784683649,"startTime":"0","endTime":"0","summary":"The latest update is out from Memphasys Ltd ( ($AU:MEM) ). Memphasys Limited, trading on the ASX as MEM, is a biotechnology and medical technology ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-plans-8-million-share-placement-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-plans-8-million-share-placement-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","AGNG","XT","FHLC","RSPH","IBB","LNGR","IEIH","XHE","DTEC","MEM","SYNB","JDOC","BK4585","FWD","DARP","BBP","BK4588","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653862677","title":"Trex Acquisition Appoints Post Oak As M&A Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2653862677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653862677?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:48","pubTimestamp":1784670496,"startTime":"0","endTime":"0","summary":"Trex Acquisition ( ($TRXA) ) has provided an update. Trex Acquisition operates in the mergers and acquisitions space, focusing on corporate transac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trex-acquisition-appoints-post-oak-as-ma-advisor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trex-acquisition-appoints-post-oak-as-ma-advisor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KCE","TREX","BK4544","BK4212","GTPE","POST","ARKX","LRCY","BK4564","ZIG","BBP","KI","PEX","BK4086","PEVC","UFO","GABF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653529241","title":"AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653529241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653529241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:47","pubTimestamp":1784587635,"startTime":"0","endTime":"0","summary":"An announcement from AFT Pharmaceuticals Ltd. ( ($NZ:AFT) ) is now available. AFT Pharmaceuticals has received tentative U.S. FDA approval for Scom...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","MEDI","BBP","IDNA","GDOC","TECB","PINK","MRNX","LABU","AFT","FRTY","IBB","SYNB","IYH","BK4588","RSPH","BMED","MRNY","LFSC","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653624696","title":"Evofem Biosciences Updates Investors via New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653624696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653624696?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:52","pubTimestamp":1784580764,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Evofem Biosciences ( ($EVFM) ). Evofem Biosciences, Inc., a biotechnology company focused on women’s health, pe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evofem-biosciences-updates-investors-via-new-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evofem-biosciences-updates-investors-via-new-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","IBB","RSPH","XT","BK4585","BBP","JDOC","FWD","BK4588","BK4211","DARP","FHLC","ISBC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652443281","title":"3 Small-Cap ETFs With More Than 20% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2652443281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652443281?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:06","pubTimestamp":1784300760,"startTime":"0","endTime":"0","summary":"Small-cap stocks have lagged large-cap peers in recent years as higher interest rates and slowing economic growth favored larger, more established ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-small-cap-etfs-with-more-than-20-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-small-cap-etfs-with-more-than-20-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEST","BK4585","KOMP","DFND","07366","TSII","ANEW","PEX","AVSD","TSLW","TSYY","BBP","TLA","TSLT","DFUV","TSLY","IMCG","TSL","09766","TSLQ","JPAN","TSLI","PEVC","BK4588","TSLG","TSLS","UCC","TSLR","TSLP","VAW","FXL","IJK","FXR","TSLZ","CRSH","QOWZ","07766","CAOS","09366","CGDV","TSLL","TSDD","TSLO","CLIX","TESL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BK4007","FRTY","SYNB","MRNX","BBP","TECB","GDOC","IDNA","IYH","BK4585","RSPH","LFSC","AMRX","BK4588","BMED","PINK","MRNY","PSCH","LABU","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652184401","title":"Arbutus Biopharma Reshapes Strategy After Moderna Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652184401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652184401?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:37","pubTimestamp":1784281058,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","USRD","MEDX","RND","ABUS","NXTI","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409835","title":"Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409835","media":"TIPRANKS","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652409835?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:48","pubTimestamp":1784278109,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Class A ( ($VRAX) ) has issued an announcement. Virax Biolabs Group Limited, a Nasdaq-listed biotechnology company focused...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","AGNG","NQmain","FHLC","LCLG","BK4588","BBP","FWD","RSPH","DARP","SYNB","IBB","XT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652471130","title":"IMF warns Bank of England against cutting interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2652471130","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652471130?lang=en_us&edition=fundamental","pubTime":"2026-07-17 11:55","pubTimestamp":1784260500,"startTime":"0","endTime":"0","summary":"The IMF said rates should remain on hold because of \"heightened uncertainty\"  The Bank of England must keep interest rates on hold for as long as risks from the Iran war persist, the International Monetary Fund has said.In its annual temperature check of Britain’s economic outlook, the fund warned rate setters to keep monetary policy “sufficiently restrictive” to avoid sparking a painful bout of inflation that becomes hard to contain.Economists have been closely monitoring the UK economy for signs that elevated oil prices caused by the Middle East conflict have led to a cascade of price rises in the wider economy.Bank of England policymakers are especially concerned about the emergence of so-called second-round effects – when an initial price shock spreads through an economy, leading workers to bargain for more wages, which in turn also gives companies breathing room to raise price further.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["TSLW","IJK","IMF","IDEV","TSLG","09366","07366","TSLP","AVSD","TSLT","UCC","CLIX","BBEU","TSLO","ISVL","CAOS","BK4585","PEVC","CGDV","DFUV","TSLI","KOMP","BK4582","FLGB","ANEW","VAW","FXL","TSYY","TSLL","TSLQ","TSLR","FXR","BBP","BK4588","TESL","09766","TSII","TSLS","CRSH","TSDD","TEST","07766","TLA","TSL","TSLY","TSLZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422420","title":"Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422420","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422420?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:35","pubTimestamp":1784234123,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) announced that the Committee for Orphan Medicinal Products at the European Medicines Agency has adopted a positive opi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","VNDA","EMA","BBP","BK4081","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120952118","title":"Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120952118","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120952118?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084075,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Attovia Therapeutics has filed for an initial public offering with the goal of raising up to $100 million.The firm plans to list on the Nasdaq exchange under...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","IBBQ","BBP","MRNX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484502","title":"Regeneron’s dupilumab granted orphan drug designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:05","pubTimestamp":1784063112,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) dupilumab was granted FDA orphan drug designation, according to a post on the agency’s website. Published first on TheFly – the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0289739699.SGD","BBP","LU0889565916.HKD","IBB","LU0823416689.USD","LU0114720955.EUR","LU1917777945.USD","BK4588","LABU","LU0109394709.USD","LU0058720904.USD","LU0053666078.USD","LU0823434740.USD","BBH","LU1974910355.USD","LU0882574055.USD","LU0823434583.USD","LU2237438978.USD","LU2089984988.USD","REGN","IBBQ","LU2362541513.USD","BK4139","BK4585","LU2106854487.HKD","LU2023250504.SGD","LU2468319806.SGD","LU2362541273.HKD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BMED","BK4588","BBP","IBB","GDOC","IDNA","PINK","FRTY","MEDI","BK4139","MRNX","RSPH","LABU","CELC","PSCH","TECB","IYH","LFSC","BK4585","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","BK4104","IYH","PSCH","CAI","LABU","SYNB","MRNY","BMED","IHC","BK4092","BBP","IBB","PINK","TECB","RSPH","PTEN","MRNX","IDNA","BK4585","LFSC","GDOC","BK4139","FRTY","BK4162","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","AGNG","BK4539","FWD","BK4139","FHLC","RSPH","XT","BK4585","BK4588","IBB","BBP","SYNB","BK4007","JDOC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4007","IBB","BK4585","BK4539","DARP","FWD","BBP","JDOC","LENZ","AGNG","SYNB","FHLC","RSPH","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251143029.SGD","IDNA","IBB","SG9999002414.USD","LU2152927971.USD","MRNY","RSPH","LU1861220207.SGD","SG9999002406.SGD","BK4535","IYH","BK4585","LU0516423091.SGD","BK4588","LU2065171402.SGD","LU2125910849.SGD","LU0532188223.SGD","SG9999013478.USD","HBCP","BBP","SYNB","BK4554","BK4211","BMED","GDOC","LFSC","MEDI","SG9999002679.SGD","LU0441851309.USD","LU0589944569.HKD","LU2360107671.USD","TECB","SG9999002620.SGD","PSCH","SG9999014484.SGD","SE","BK4503","BK4220","LABU","FDNI","SG9999014492.USD","FRTY","LU2065170008.USD","IE0031814969.USD","LU0823039010.USD","PINK","LU0516422366.SGD","MRNX","LU0516423174.USD","LU0499858438.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144496","title":"Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144496","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144496?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:57","pubTimestamp":1783976270,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics ( ($LKFT) ) has provided an update. Lakefront Biotherapeutics, a Belgium-based biotechnology company listed on Euronext a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","IBB","FHLC","SYNB","XT","JDOC","RSPH","AGNG","BK4007","DARP","BK4585","BBP","FWD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":162,"code":"91000000","status":"200"}]}}